Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Retinopathy | 4 | 2026 | 211 | 1.480 |
Why?
|
| Tomography, Optical Coherence | 11 | 2026 | 270 | 1.460 |
Why?
|
| Retinal Vessels | 3 | 2026 | 77 | 1.140 |
Why?
|
| Capillaries | 2 | 2026 | 125 | 1.080 |
Why?
|
| Retinal Ganglion Cells | 3 | 2026 | 123 | 1.030 |
Why?
|
| Glaucoma | 7 | 2021 | 251 | 0.720 |
Why?
|
| Choroid | 3 | 2022 | 80 | 0.580 |
Why?
|
| Glaucoma, Angle-Closure | 4 | 2019 | 23 | 0.450 |
Why?
|
| Optic Disk | 4 | 2020 | 53 | 0.420 |
Why?
|
| Nerve Fibers | 3 | 2026 | 105 | 0.420 |
Why?
|
| Visual Fields | 4 | 2021 | 116 | 0.380 |
Why?
|
| Fluorescein Angiography | 5 | 2026 | 189 | 0.360 |
Why?
|
| Glaucoma, Open-Angle | 4 | 2014 | 104 | 0.350 |
Why?
|
| Visual Acuity | 4 | 2026 | 490 | 0.340 |
Why?
|
| Graves Ophthalmopathy | 2 | 2022 | 13 | 0.340 |
Why?
|
| Intraocular Pressure | 6 | 2020 | 330 | 0.300 |
Why?
|
| India | 7 | 2021 | 213 | 0.300 |
Why?
|
| Electroretinography | 1 | 2026 | 51 | 0.240 |
Why?
|
| Cross-Sectional Studies | 7 | 2026 | 5925 | 0.200 |
Why?
|
| ROC Curve | 1 | 2026 | 618 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 2602 | 0.170 |
Why?
|
| Optometrists | 1 | 2021 | 12 | 0.170 |
Why?
|
| Eye | 1 | 2021 | 112 | 0.160 |
Why?
|
| Macular Edema | 1 | 2021 | 49 | 0.160 |
Why?
|
| Middle Aged | 14 | 2026 | 36309 | 0.160 |
Why?
|
| Ophthalmology | 2 | 2019 | 120 | 0.150 |
Why?
|
| Aged | 9 | 2026 | 26217 | 0.150 |
Why?
|
| Adult | 14 | 2026 | 40882 | 0.150 |
Why?
|
| Conjunctivitis, Allergic | 1 | 2019 | 4 | 0.150 |
Why?
|
| Cornea | 1 | 2020 | 154 | 0.150 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2019 | 4 | 0.140 |
Why?
|
| Blindness | 1 | 2019 | 51 | 0.140 |
Why?
|
| Steroids | 1 | 2019 | 160 | 0.140 |
Why?
|
| Organ Size | 2 | 2015 | 461 | 0.130 |
Why?
|
| Gonioscopy | 4 | 2019 | 11 | 0.110 |
Why?
|
| Male | 15 | 2026 | 73012 | 0.110 |
Why?
|
| Trabeculectomy | 2 | 2013 | 75 | 0.110 |
Why?
|
| Retinal Telangiectasis | 1 | 2014 | 2 | 0.110 |
Why?
|
| Female | 15 | 2026 | 79045 | 0.110 |
Why?
|
| Ectopia Lentis | 1 | 2014 | 1 | 0.100 |
Why?
|
| Iris | 1 | 2014 | 23 | 0.100 |
Why?
|
| Macula Lutea | 1 | 2014 | 21 | 0.100 |
Why?
|
| Corneal Diseases | 1 | 2014 | 46 | 0.100 |
Why?
|
| Epidemiologic Research Design | 1 | 2013 | 29 | 0.100 |
Why?
|
| Tonometry, Ocular | 4 | 2014 | 104 | 0.100 |
Why?
|
| Epidemiologic Methods | 1 | 2013 | 91 | 0.100 |
Why?
|
| Antihypertensive Agents | 2 | 2014 | 521 | 0.090 |
Why?
|
| Humans | 19 | 2026 | 145785 | 0.090 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2012 | 53 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2021 | 1101 | 0.090 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 49 | 0.090 |
Why?
|
| Vision Disorders | 1 | 2013 | 179 | 0.090 |
Why?
|
| Phacoemulsification | 1 | 2013 | 123 | 0.080 |
Why?
|
| Prevalence | 4 | 2019 | 2875 | 0.080 |
Why?
|
| Telemedicine | 1 | 2019 | 967 | 0.080 |
Why?
|
| Cataract | 1 | 2013 | 238 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2022 | 8078 | 0.080 |
Why?
|
| Rural Population | 1 | 2013 | 661 | 0.070 |
Why?
|
| Age Distribution | 2 | 2019 | 404 | 0.070 |
Why?
|
| Molecular Biology | 2 | 2019 | 58 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2020 | 17330 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2015 | 2344 | 0.060 |
Why?
|
| Young Adult | 5 | 2022 | 14254 | 0.050 |
Why?
|
| Visual Field Tests | 2 | 2013 | 32 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 8347 | 0.040 |
Why?
|
| Axial Length, Eye | 1 | 2020 | 16 | 0.040 |
Why?
|
| Capacity Building | 1 | 2021 | 62 | 0.040 |
Why?
|
| Photography | 1 | 2021 | 119 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 219 | 0.040 |
Why?
|
| Anterior Chamber | 1 | 2019 | 26 | 0.040 |
Why?
|
| Fundus Oculi | 1 | 2019 | 89 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2019 | 388 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 2110 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 3634 | 0.030 |
Why?
|
| Logistic Models | 1 | 2019 | 2139 | 0.020 |
Why?
|
| Vitrectomy | 1 | 2014 | 73 | 0.020 |
Why?
|
| Adolescent | 3 | 2019 | 22577 | 0.020 |
Why?
|
| Laser Coagulation | 1 | 2014 | 80 | 0.020 |
Why?
|
| Age Factors | 1 | 2020 | 3346 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2013 | 61 | 0.020 |
Why?
|
| Scanning Laser Polarimetry | 1 | 2012 | 2 | 0.020 |
Why?
|
| Anthropometry | 1 | 2013 | 206 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2014 | 136 | 0.020 |
Why?
|
| Mass Screening | 1 | 2021 | 1361 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 319 | 0.020 |
Why?
|
| Developing Countries | 1 | 2013 | 317 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5428 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 10919 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2000 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1898 | 0.020 |
Why?
|
| Child | 2 | 2019 | 22740 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 2865 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3418 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 1851 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 2933 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2014 | 6465 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 10091 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 11794 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 11868 | 0.010 |
Why?
|